News
Partnerships Are No Longer Optional in Biologicals
3+ hour, 12+ min ago (145+ words) Agri Business Global Partnerships Are No Longer Optional in Biologicals As the biologicals sector expands, partnerships are becoming one of the industry's most important growth drivers. In this discussion, Sebastian Bachem, CEO of Accumont; Jos" Nolasco, Head of Global R…...
Syngene Names Former Biocon CEO Siddharth Mittal as Managing Director and CEO
2+ hour, 27+ min ago (378+ words) Medical Dialogues New Delhi: Syngene International Limited has announced the appointment of Siddharth Mittal as its Managing Director and Chief Executive Officer (MD & CEO), effective July 1, 2026 He succeeds Peter Bains, who completed his tenure as MD & CEO on June 30, 2026. Syngene,…...
Automated And Closed Cell Therapy Processing Systems Market Report 2026 Market Outlook Supported By A Forecast 16. 7% CAGR
7+ hour, 17+ min ago (68+ words) Automated And Closed Cell Therapy Processing Systems Market open PR. com Automated And Closed Cell Therapy Processing Systems Market Report 2026 Market Outlook Supported By A Forecast 16. 7% CAGR Press release from: The Business Research Company Permanent link to this press release:…...
Syngulora - $1 M Raised, Investors, Team & Alternatives
12+ hour ago (147+ words) Syngulora - $1 M Raised - Reviews & Alternatives Startup Hub. ai AI-powered platform for optimizing and automating scientific research and development. No comments yet. Be the first to share your take. What does Syngulora do? Syngulora is developing an AI-powered platform designed to…...
Bio NTech has held talks with buyers over four German sites set to close, Handelsblatt says
8+ hour, 39+ min ago (164+ words) BERLIN, July 3 (Reuters) " Bio NTech has held confidential talks with potential buyers about German sites "that the COVID19 vaccine "maker plans to close, the Handelsblatt newspaper reported on Friday. The German company said in May it would close "three "sites in…...
Scribe Therapeutics joins the IPO queue
9+ hour, 30+ min ago (423+ words) Scribe's president and CEO, Benjamin Oakes Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq, in what is being seen as a test of the appetite among investors for earlier-stage drug developers. Scribe " which…...
Kane Biotech (TSX-V: KNE) Strengthens revyve" Commercialization Across North America
3+ hour, 34+ min ago (335+ words) Why Growth Stocks Need Stronger Quality Signals On TSX? TSX Gold Stocks Enter Spotlight As Execution Takes Priority Gold Stocks Rotation Signals to Watch Across The TSX Smallcap Index Gold Stocks On TSX Reflect Changing Market Mood Targeting Biofilms in…...
SL Science Holding Shares Surge 35% on Nasdaq Debut After SPAC Merger as Biotech Investor Interest Builds
6+ hour, 39+ min ago (531+ words) SL Science Holding Limited shares soared more than 34% to close at $5. 99 Thursday following its recent listing on the Nasdaq Global Market through a business combination with a special purpose acquisition company, highlighting strong investor appetite for innovative cell therapy platforms…...
Anthropic plans to create its own drugs
5+ hour, 8+ min ago (173+ words) Anthropic has decided to develop its own drugs. Head of Life Sciences Eric Kauderer-Abrams said the company will focus on finding treatments for "neglected" diseases. AI companies have long sought to win over customers from the scientific and pharmaceutical sectors:…...
US Biotech Loses UPC Bid To Block Rival's Biopsy Kit Sales
3+ hour ago (67+ words) Law360 Try our Advanced Search for more refined results The Practice of Law Deep News & Analysis Law360 | The Practice of Law Law360 Authority | Deep News & Analysis Law360 Pulse | The Business of Law US Biotech Loses UPC Bid To Block Rival's Biopsy Kit Sales Law360 is…...